Progress in developing cationic vectors for non-viral systemic gene therapy against cancer, Biomaterials, vol.29, issue.24-25, pp.3477-96, 2008. ,
DOI : 10.1016/j.biomaterials.2008.04.036
URL : https://hal.archives-ouvertes.fr/inserm-00353462
Pharmacokinetics and in vivo drug release rates in liposomal nanocarrier development, Journal of Pharmaceutical Sciences, vol.97, issue.11, pp.4696-740, 2008. ,
DOI : 10.1002/jps.21358
Long-circulating and target-specific nanoparticles: theory to practice, Pharmacol Rev, vol.53, pp.283-318, 2001. ,
Complement activation by injectable colloidal drug carriers, Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids, pp.187-230, 2005. ,
Molecular Organization and Function of the Complement System, Annual Review of Biochemistry, vol.57, issue.1, pp.321-343, 1988. ,
DOI : 10.1146/annurev.bi.57.070188.001541
Complement and Complement fixation Experimental immunochemistry; énd edn, pp.133-156, 1961. ,
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes, FEBS Letters, vol.3, issue.1, pp.235-242, 1990. ,
DOI : 10.1016/0014-5793(90)81016-H
Large unilamellar liposomes with low uptake into the reticuloendothelial system, FEBS Letters, vol.557, issue.1, pp.42-48, 1987. ,
DOI : 10.1016/0014-5793(87)80506-9
Clinical Studies of Liposome-Encapsulated Doxorubicin, Acta Oncologica, vol.100, issue.7, pp.779-786, 1994. ,
DOI : 10.1073/pnas.85.18.6949
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, Journal of Controlled Release, vol.65, issue.1-2, pp.271-84, 2000. ,
DOI : 10.1016/S0168-3659(99)00248-5
A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs, Cancer Res, vol.46, pp.6387-92, 1986. ,
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006. ,
DOI : 10.1002/jbm.a.30711
Influence of surface charge and inner composition of porous nanoparticles to cross blood???brain barrier in vitro, International Journal of Pharmaceutics, vol.344, issue.1-2, pp.103-112, 2007. ,
DOI : 10.1016/j.ijpharm.2007.06.023
Design and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations, Antimicrobial Agents and Chemotherapy, vol.46, issue.5, pp.1597-601, 2002. ,
DOI : 10.1128/AAC.46.5.1597-1601.2002
Intranasal immunization with recombinant antigens associated with new cationic particles induces strong mucosal as well as systemic antibody and CTL responses, Vaccine, vol.20, issue.21-22, pp.2752-63, 2002. ,
DOI : 10.1016/S0264-410X(02)00191-3
A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration, European Journal of Cancer, vol.37, issue.8, pp.1053-60, 2001. ,
DOI : 10.1016/S0959-8049(01)00084-3
Enhancement of Protective Efficacy following Intranasal Immunization with Vaccine Plus a Nontoxic LTK63 Mutant Delivered with Nanoparticles, Infection and Immunity, vol.70, issue.9, pp.4785-90, 2002. ,
DOI : 10.1128/IAI.70.9.4785-4790.2002
Biovector nanoparticles improve antinociceptive efficacy of nasal morphine, Pharmaceutical Research, vol.17, issue.6, pp.743-751, 2000. ,
DOI : 10.1023/A:1007594602449
Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation, Journal of Allergy and Clinical Immunology, vol.120, issue.2, pp.278-85, 2007. ,
DOI : 10.1016/j.jaci.2007.04.009
Evaluation of effect of charge and lipid coating on ability of 60-nm nanoparticles to cross an in vitro model of the blood-brain barrier, J Pharmacol Exp Ther, vol.291, pp.1017-1039, 1999. ,
URL : https://hal.archives-ouvertes.fr/hal-00534808
Characterisation and phase behaviour of phospholipid bilayers adsorbed on spherical polysaccharidic nanoparticles, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1327, issue.1, pp.32-40, 1997. ,
DOI : 10.1016/S0005-2736(97)00041-2
[9] Liposome preparation and size characterization, Methods Enzymol, vol.171, pp.193-217, 1989. ,
DOI : 10.1016/S0076-6879(89)71012-0
Development of a new method to characterize (SMBV???) antigen formulations using surface plasmon resonance technology, International Journal of Pharmaceutics, vol.242, issue.1-2, pp.411-416, 2002. ,
DOI : 10.1016/S0378-5173(02)00227-2
What can light scattering spectroscopy do for membrane-active peptide studies?, Journal of Peptide Science, vol.107, issue.4, pp.394-400, 2008. ,
DOI : 10.1002/psc.1007
Characterization of the Soluble Nanoparticles Formed through Coulombic Interaction of Bovine Serum Albumin with Anionic Graft Copolymers at Low pH, Biomacromolecules, vol.8, issue.4, pp.1195-1199, 2007. ,
DOI : 10.1021/bm061094t
URL : https://hal.archives-ouvertes.fr/hal-00149285
Electrokinetics of soft particles, Colloid and Polymer Science, vol.21, issue.80, pp.1411-1421, 2007. ,
DOI : 10.1007/s00396-007-1740-7
Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface, ELECTROPHORESIS, vol.15, issue.11, pp.2066-75, 2005. ,
DOI : 10.1002/elps.200410145
Physicochemical determinants for the interactions of magainins 1 and 2 with acidic lipid bilayers, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1063, issue.1, pp.162-70, 1991. ,
DOI : 10.1016/0005-2736(91)90366-G
Proofs of the structure of lipid coated nanoparticles (SMBV) used as drug carriers, Pharmaceutical Research, vol.17, issue.7, pp.817-841, 2000. ,
DOI : 10.1023/A:1007504124603
Electrophoretic Mobility of Soft Particles, Journal of Colloid and Interface Science, vol.163, issue.2, pp.474-483, 1994. ,
DOI : 10.1006/jcis.1994.1126
Plant protein???polysaccharide interactions in solutions: application of soft particle analysis and light scattering measurements, Colloids and Surfaces B: Biointerfaces, vol.41, issue.2-3, pp.95-102, 2005. ,
DOI : 10.1016/j.colsurfb.2004.10.031
Phagocytic uptake of polystyrene microspheres by alveolar macrophages: effects of the size and surface properties of the microspheres, Colloids and Surfaces B: Biointerfaces, vol.27, issue.1, pp.33-39, 2003. ,
DOI : 10.1016/S0927-7765(02)00042-5
Interaction between charged soft microcapsules and red blood cells: effects of PEGylation of microcapsule membranes upon their surface properties, Colloids and Surfaces B: Biointerfaces, vol.13, issue.6, pp.287-297, 1999. ,
DOI : 10.1016/S0927-7765(99)00041-7
Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties, Pharmaceutical Research, vol.134, issue.109, pp.2190-2199, 2006. ,
DOI : 10.1007/s11095-006-9061-y
Strategy forin vitro evaluation of the interactions between biomaterials and complement system, Journal of Applied Biomaterials, vol.9, issue.3, pp.231-240, 1993. ,
DOI : 10.1002/jab.770040304
Long-circulating nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate), Pharmaceutical Research, vol.15, issue.7, pp.1046-50, 1998. ,
DOI : 10.1023/A:1011930127562
Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats, European Journal of Pharmaceutics and Biopharmaceutics, vol.46, issue.3, pp.255-63, 1998. ,
DOI : 10.1016/S0939-6411(98)00038-1
Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-73, 2006. ,
DOI : 10.1016/j.biomaterials.2006.03.039
Interaction of liposomes with blood plasma proteins, Biochem Soc Trans, vol.4, pp.253-259, 1976. ,
Relationship between reduction of complement activation by polysaccharide surfaces bearing diethylaminoethyl groups and their degree of substitution, Biomaterials, vol.16, issue.14, pp.1081-1089, 1995. ,
DOI : 10.1016/0142-9612(95)98904-S
The ability of sephadex to activate human complement is suppressed in specifically substituted functional sephadex derivatives, Molecular Immunology, vol.25, issue.2, pp.165-71, 1988. ,
DOI : 10.1016/0161-5890(88)90064-8
Binding reaction between the third human complement protein and small molecules, Biochemistry, vol.20, issue.26, pp.7457-63, 1981. ,
DOI : 10.1021/bi00529a020
Complement activation by substituted polyacrylamide hydrogels for embolisation and implantation, Biomaterials, vol.23, issue.11, pp.2319-2346, 2002. ,
DOI : 10.1016/S0142-9612(01)00366-0
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, International Journal of Pharmaceutics, vol.307, issue.1, pp.93-102, 2006. ,
DOI : 10.1016/j.ijpharm.2005.10.010
The role of surface charge and hydrophilic groups on liposome clearance in vivo, Biochimica et Biophysica Acta (BBA) - Biomembranes, vol.1103, issue.1, pp.94-100, 1992. ,
DOI : 10.1016/0005-2736(92)90061-P
[Role of the complement C3 protein in the control of the specific immune response], Ann Biol Clin, vol.57, pp.127-162, 1999. ,
PEO coated magnetic nanoparticles for biomedical application, European Polymer Journal, vol.44, pp.3191-3199, 2008. ,
pH-Responsive Flower-Type Micelles Formed by a Biotinylated Poly(2-vinylpyridine)-block-poly(ethylene oxide)-block-poly(?caprolactone ) Triblock Copolymer, Advanced Functional Materials, vol.19, pp.1416-1425, 2009. ,
Synthesis and pH-dependent micellization of diblock copolymer mixtures, J Colloid Interface Sci, vol.329, pp.235-278, 2009. ,
URL : https://hal.archives-ouvertes.fr/inserm-00343572
Novel composite core-shell nanoparticles as busulfan carriers, Journal of Controlled Release, vol.111, issue.3, pp.271-80, 2006. ,
DOI : 10.1016/j.jconrel.2006.01.002
Synthesis of Amphiphilic Copolymers of Poly(ethylene oxide) and Poly(??-caprolactone) with Different Architectures, and Their Role in the Preparation of Stealthy Nanoparticles, Advanced Functional Materials, vol.98, issue.11, pp.1506-1514, 2006. ,
DOI : 10.1002/adfm.200500110